A civil suit filed in British Columbia claims OpenAI, the company behind the 'ChatGPT' artificial intelligence tool, possessed prior awareness of a planned mass casualty event. The lawsuit, brought forth by the parents of Maya Gebala, alleges that the tech firm knew the individual responsible for a February 10th school shooting in Tumbler Ridge was using its platform to plan the attack. This prior knowledge, the suit contends, led directly to Ms. Gebala suffering critical injuries.
The shooting, described as one of Canada's worst, left Maya Gebala with devastating wounds. She was shot three times at close range, sustaining injuries to her head and neck, with a third bullet grazing her cheek. The legal filing asserts this has resulted in a "catastrophic brain injury," expected to cause lifelong cognitive and physical impairments. Details emerging suggest Ms. Gebala was injured while attempting to secure a library door against the assailant.
Read More: Supreme Court Asks for Same Acid Attack Laws for BNS and RPwD Act
OpenAI's response, according to reports, acknowledges consideration of the shooter's activities but states no alert was issued to law enforcement. The company has not immediately commented on the specific allegations within the lawsuit.
The legal action, initiated in the British Columbia Supreme Court, directly targets OpenAI's conduct. The claim posits that the company had "specific knowledge of the shooter utilising ChatGPT to plan a mass casualty event like the Tumbler Ridge mass shooting." The extent of this alleged knowledge and the company's internal deliberations regarding potential threats are now central to the proceedings.
The incident at Tumbler Ridge, British Columbia, has brought into sharp focus the societal implications of advanced AI technologies and the responsibilities of their creators. The lawsuit represents a significant challenge to the understanding of accountability in cases where AI platforms may be implicated in real-world violence.
Read More: Telangana Police Needs More Tech and Experts for Cybercrime and Drugs